🇺🇸 Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in United States

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf in United States?

Genentech, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.